CranioSacral Therapy for Parkinson's Disease

Age: 18+

Sex: Any

Trial Phase: Academic

Sponsor: Zia, Al Raza

Disqualifiers: No Parkinson's Disease

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Compensation: Varies

Number of Visits: 6

Duration: 12 weeks

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial explores how CranioSacral Integrative Therapy, a hands-on technique, might benefit people with Parkinson's Disease. Participants will receive 90-minute therapy sessions twice a month for three months, totaling nine hours. Researchers aim to observe improvements in symptoms and overall quality of life. Individuals with Parkinson's Disease interested in this therapy might be suitable candidates for the study. As an unphased trial, this study provides a unique opportunity to explore a novel therapy that could enhance quality of life.

Do I have to stop taking my current medications for the trial?

The trial information does not specify whether you need to stop taking your current medications. It's best to ask the trial organizers for more details.

What prior data suggests that CranioSacral Therapy is safe for Parkinson's Disease patients?

Research has shown that CranioSacral Therapy (CST) is generally safe. A review of studies on CST for various health issues found no major safety problems, with most people experiencing only minor side effects, such as mild discomfort during or after sessions.

For individuals with Parkinson's Disease, studies on CST have not identified any major safety concerns, indicating that CST appears to be a safe option for these patients. However, because CST has not been extensively studied for Parkinson's, further research could provide clearer information in the future.

In summary, current research suggests that CST is safe, with few side effects reported. Participants should still consult their healthcare providers about any concerns before starting the therapy. ^{1 2 3 4 5}

Why are researchers excited about this trial?

CranioSacral Therapy for Parkinson's Disease is unique because it offers a non-invasive, holistic approach, unlike standard treatments that typically involve medications or deep brain stimulation. Researchers are excited about this therapy because it targets the nervous system by gently manipulating the craniosacral rhythm, potentially reducing symptoms without the side effects commonly associated with drugs. This therapy could complement existing treatments, providing a new avenue for symptom management and improving patients' quality of life.

What evidence suggests that CranioSacral Therapy is effective for Parkinson's Disease?

Research has shown that CranioSacral Therapy (CST) might alleviate symptoms of Parkinson's Disease. One study found that participants experienced improved thinking skills, clearer speech, better balance, and reduced muscle stiffness. This therapy also enhanced their breathing and ease of movement. Although more research is needed, these early results suggest CST could aid in managing Parkinson's symptoms. Participants in this trial will receive a biweekly intervention to further evaluate CST's effects on Parkinson's symptoms. ^{3 6 7 8 9}

Who Is on the Research Team?

Al Raza, CST

Principal Investigator

IBR, Inc.

Are You a Good Fit for This Trial?

This trial is for individuals who have been diagnosed with Parkinson's Disease. It aims to include those specifically suffering from this condition and excludes anyone who does not have Parkinson's Disease.

Inclusion Criteria

I have been diagnosed with Parkinson's Disease.

Exclusion Criteria

I do not have Parkinson's Disease.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive CranioSacral Integrative therapy for Parkinson's Disease, with biweekly sessions lasting 90 minutes each over 3 months

12 weeks

6 visits (in-person)

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

• Biweekly Intervention

Trial Overview The study is testing the effects of CranioSacral Integrative Therapy on patients with Parkinson's Disease over a period of 3 months, involving biweekly therapy sessions lasting 90 minutes each.

How Is the Trial Designed?

Group I: biweekly intervention Experimental Treatment 1 Intervention

biweekly intervention

Who Is Running the Clinical Trial?

Zia, Al Raza

Lead Sponsor

Trials

1

Recruited

5+

Citations

1. pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov/articles/PMC2957248/

Feasibility of Using Cranial Electrotherapy Stimulation for Pain ... Results. Persons receiving active CES had, on average, a 1.14-point decrease in pain compared with a 0.23-point decrease for those receiving sham CES (Wilcoxon ...

2. pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov/articles/PMC11487524/

Effectiveness of osteopathic craniosacral techniques This paper seeks to systematically review and conduct a meta-analysis of randomized controlled trials assessing the clinical effectiveness of CST.

3. mdpi.com mdpi.com/2227-9032/12/6/679

Is Craniosacral Therapy Effective? A Systematic Review ... The aim of this study was to evaluate the clinical effectiveness of craniosacral therapy (CST) in the management of any conditions.

4. iahe.com iahe.com/storage/docs/articles/CranioSacral-Therapy-n-Parkinson-s-Disease.pdf

CranioSacral Therapy – Parkinson's Disease Client has shown an improvement in cognitive abilities, and speech patterns, balance and softening of muscle rigidity. Increase in breath and extension through ...

5. sciencedirect.com sciencedirect.com/science/article/abs/pii/S1877573X13000154

An evidence-based osteopathic approach to Parkinson ... OMT can be particularly helpful in treating patients with PD when supporting functional gains or minimizing decline over time. Considering the promising results ...

6. pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov/articles/PMC10970181/

Is Craniosacral Therapy Effective? A Systematic Review ... The aim of this study was to evaluate the clinical effectiveness of craniosacral therapy (CST) in the management of any conditions.

7. clinicaltrials.gov clinicaltrials.gov/study/NCT01989013

Effect on Parkinson's Disease After Therapeutic Induction ... Also called a data safety and monitoring board, or DSMB. ... We are studying & researching the effect of CranioSacral I therapy on Parkinson's Disease.

8. accessdata.fda.gov accessdata.fda.gov/cdrh_docs/pdf14/P140009S039B.pdf

fda - summary of safety and effectiveness data (ssed) The study was used to support the safety of DBS at therapeutic levels for. Parkinson's disease. ... Parkinson's Control Therapy and is summarized as follows.

9. va.gov va.gov/wholehealthlibrary/passport/chapter-16.asp

Passport to Whole Health: Chapter 16 A 2010 study of 80 patients found that, compared with those receiving massage therapy, the group receiving SMT had greater improvements in pain and disability.